XSHG
603363
Market cap1.13bUSD
Oct 09, Last price
2.84CNY
1D
2.16%
1Q
-3.40%
IPO
-51.36%
Name
Fujian Aonong Biological Technology Group Incorporation Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Fujian Aonong Biological Technology Group Incorporation Limited operates across diverse sectors, including animal feed production, swine farming, agricultural raw material trading, digital agricultural platforms, and bio-pharmaceuticals, serving both domestic Chinese and international markets. Its activities encompass the research, development, manufacturing, and distribution of various animal feed products, including specialized formulations for pigs, poultry, aquatic species, and ruminants. Furthermore, the company manages pig breeding facilities and is involved in the processing and slaughtering of swine. Aonong Biological Technology also supplies a range of veterinary products, such as vaccines, medicinal preparations, micro-ecological agents, powdered supplements, premixes, liquid oral treatments, feed additives, and disinfectants. Additionally, it develops and maintains an intelligent platform designed to support breeding services. Established in Xiamen, China, the company commenced operations in 2011.
Key people
Mingcheng Su
Chairman of the Board · since 2025
Youlin Wu
Vice Chairman of the Board, General Manager · since 2025
Shaoyong Hu
Deputy General Manager · since 2024
Bingchun Jiang
Deputy General Manager · since 2024
Qiang Lin
Deputy General Manager · since 2024
Zhou Yang
Chief Financial Officer, Deputy General Manager · since 2025
Jiang Peng
Deputy General Manager, Secretary of the Board · since 2024
Jiangfu Cai
Director · since 2024
Mingyi Chen
Director · since 2025
Haozhe Li
Director · since 2025
Jinglong Li
Director · since 2025
Independent Director · since 2021
Independent Director · since 2025
Daojin Yu
Independent Director · since 2025
Luying Zheng
Independent Director · since 2021
Headquarters & legal address
福建省漳州市芗城区金峰经济开发区兴亭路与宝莲路交叉处
漳州市, FJ 350000
CN
漳州市, FJ 350000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||